Garanzini Michael 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Jul 12, 2018
Insider Transaction Report
Form 4
Garanzini Michael
Chief Commercial Officer
Transactions
- Award
Common Stock
2018-07-10+25,000→ 196,250 total
Footnotes (1)
- [F1]Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The restrictions will vest as to one-third (1/3) of the shares on July 10, 2019, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years.